Cyproterone Acetate Market Growth Driven by Rising Incidences of Prostate Cancer

The Global Cyproterone Acetate Market is estimated to be valued at US$ 327.1 million in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031.

The cyproterone acetate market has witnessed steady growth over the past few years owing to increased usage of the drug for the treatment of prostate cancer and precocious puberty. Cyproterone acetate is an anti-androgenic steroid primarily used for treating prostate cancer in men along with symptoms of benign prostatic hyperplasia such as difficulty in urinating, frequent urination, and retained urine. It helps in blocking the effects of androgen hormones like testosterone which promote the growth of cancer cells in men.

Cyproterone Acetate Market- https://themediumblog.com/...

#CoherentMarketInsights #HormoneTherapy #CyproteroneAcetate #CyproteroneAcetateMarket #CyproteroneAcetateMarketSize